Pharmacological characterization of dopamine, norepinephrine and serotonin release in the rat prefrontal cortex by neuronal nicotinic acetylcholine receptor agonists

Brain Research

Volumn 990, Issue 1-2, 2003, Pages 203-208

  Rao, Tadimeti S ^a,b   Correa, Lucia D ^a   Adams, Pamala ^a   Santori, Emily M ^a   Sacaan, Aida I ^a,c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Kalypsys Inc   (United States)

^c Arizeke Pharmaceuticals Inc   (United States)

Author keywords

Catecholamine and serotonin release; Neuronal nicotinic acetylcholine receptor; Nicotine; Prefrontal cortex

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; CALCIUM ION; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CYTISINE; DIHYDRO BETA ERYTHROIDINE; DOPAMINE; EPIBATIDINE; MECAMYLAMINE; NEUROTRANSMITTER; NICOTINE; NICOTINIC AGENT; NORADRENALIN; SEROTONIN; SODIUM CHANNEL BLOCKING AGENT; TETRODOTOXIN; TUBOCURARINE CHLORIDE;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG EFFECT; MALE; NONHUMAN; NORADRENALIN RELEASE; PHARMACOLOGICAL BLOCKING; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE;

EID: 0141987867     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)03532-7     Document Type: Article

References (39)

1. Bontempi B., Whelan K.T., Risbrough V.B., Rao T.S., Buccafusco J.J., Lloyd G.K., Menzaghi F. SIB-1553A, ((± )-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thiophenol hydrochloride, a subtype selective ligand for nicotinic acetylcholine receptors with putative cognitive-enhancing properties: effects on working and reference memory performances in aged rodents and non human primates. J. Pharmacol. Exp. Ther. 299:2001;297-306.
2. Chavez-Noriega L.E., Crona J.H., Washburn M.S., Urrutia A., Elliott K.E., Johnson E.C. Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors hα2β2, hα2β4, hα3β2, hα4β2, hα4β4 and hα7 expressed in xenopus oocytes. J. Pharmacol. Exp. Ther. 280:1997;346-356.
3. Clarke P.B.S., Pert A. Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res. 348:1985;355-358.
4. 3H]-dopamine release. Br. J. Pharmacol. 117:1996;595-606.
5. Cooper J.R., Bloom F.E., Roth R.H. The Biochemical Basis of Neuropharmcology. 1996;Oxford Univ. Press, New York, NY.
6. Dunnett S.B., Everitt B.J., Robins T.W. The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions. Trends Neurosci. 14:1991;494-500.
7. 3H]-dopamine release from synaptosomes prepared from mouse striatum. J. Neurochem. 59:1992;848-856.
8. Grannon S., Poucet B., Thomas-Blanc C., Changeux J.-P., Vidal C. Nicotinic and muscarinic receptors in the rat prefrontal cortex: differential roles in working memory, response selection and effortful processing. Psychopharmacology. 119:1995;139-144.
9. Harvey S.C., Leutje C.W. Determinants of competitive antagonist effects of nicotine on neuronal nicotinic receptor β subunits. J. Neurosci. 16:1996;3798-3806.
10. 3H]-5-hydroxytryptamine by nicotinic and muscarinic receptors in the rat hypothalamic slices. Arch. Int. Pharmacodyn. Ther. 296:1997;91-97.
11. 3H]-dopamine release from rat striatal synaptosomes and slices. J. Neurochem. 70:1998;1069-1076.
12. Kenny P.J., File S.J., Neal M.J. Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release. J. Neurochem. 75:2000;2409-2414.
13. Kulak J.M., Nguyen T.A., Olivera B.M., McIntosh J.M. α-Conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes. J. Neurosci. 17:1997;5263-5270.
14. Lambe E.K., Picciotto M.R., Aghajanian G.K. Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex. Neuropsychopharmacology. 28:2003;216-225.
15. 3H]-5-HT from rat hippocampal slices. Neuropharmacology. 35:1996;1769-1777.
16. Luetje C.W., Patrick J. Both α- and β-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J. Neurosci. 11:1991;837-845.
17. Luo S., Kulak J.M., Cartier G.D., Jacobsen R.B., Yoshikami D., Olivera B.M., McIntosh J.M. α-Conotoxin AuIB selectively blocks α3β4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release. J. Neurosci. 18:1998;8571-8579.
18. Marks M., Stitzel J.A., Romm E., Wehner J.M., Collins A.C. Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine and α-bungarotoxin. J. Pharmacol. Exp. Ther. 30:1986;427-436.
19. Marshall D., Soliakov L., Redfern P., Wonnacott S. Tetrodotoxin-sensitivity of nicotine-evoked dopamine release from rat striatum. Neuropharmacology. 35:1996;1531-1536.
20. Mitchell S.N., Brazell M.P., Joseph M., Alavijeh M.S., Gray J.A. Regionally specific effects of acute and chronic nicotine on rates of catecholamine and 5-hydroxytryptamine synthesis in rat brain. Eur. J. Pharmacol. 167:1989;311-312.
21. Nayak S.V., Ronde P., Spier A.D., Lummis S.C., Nichols R.A. Nicotinic receptors co-localize with 5-HT3 serotonin receptors on striatal nerve terminals. Neuropharmacology. 39:2000;2681-2690.
22. Newhouse P., Potter A., Levin E.D. Nicotinic system involvement in Alzheimer's disease and Parkinson's disease: implications for therapeutics. Drugs Aging. 11:1997;206-288.
23. 3H]-dopamine release from rat cortex and striatum. Neuropharmacology. 39:2000;2673-2680.
24. Rao T.S., Correa L.D., Reid R.T., Lloyd G.K. Evaluation of anti-nociceptive effects of neuronal nicotinic acetylcholine receptor (nAChR) ligands in the rat tail-flick assay. Neuropharmacology. 35:1996;393-405.
25. Rao T.S., Reid R.T., Saccan A.I., Lloyd G.K. Pharmacological characterization of neuronal nicotinic acetylcholine receptor-mediated neurotransmitter release in vitro and in vivo. Proc. Winter Conf. Brain Res. 1998;. Snow Bird, UT, #73.
26. Role L., Berg D.K. Nicotinic receptors in the development and modulation of CNS synapses. Neuron. 16:1996;1077-1085.
27. 3H]-DA release by nicotine in rat nucleus accumbens. J. Neurochem. 49:1987;1449-1454.
28. Sacaan A.I., Dunlop J.L., Lloyd G.K. Pharmacological characterization of neuronal acetylcholine-gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. J. Pharmacol. Exp. Ther. 274:1995;224-230.
29. Sacaan A.I., Menzaghi F.M., Dunlop J.L., Correa L.D., Whelan K.T., Lloyd G.K. Epibatidine: a nicotinic acetylcholine-receptor agonist releases monoaminergic neurotransmitters. In vitro and in vivo evidence in rats. J. Pharmacol. Exp. Ther. 276:1996;509-515.
30. Sacaan A.I., Santori E.M., Keegan M., Lloyd G.K., Rao T.S. Dopamine and norepinephrine release from rat prefrontal cortex is regulated by different nicotinic acetylcholine receptor subtypes. Soc. Neurosci. Abs. 23:1997;477.
31. Sargent P.B. The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16:1993;403-443.
32. 3H]-acetylcholine on catecholamine and serotonin axons in brain. J. Neurochem. 42:1984;1495-1498.
33. Ungerstedt U. Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol. Scand., Suppl. 367:1971;1-20.
34. Vidal C., Changeux J.-P. Nicotinic and muscarinic modulations of excitatory synaptic transmission in the rat prefrontal cortex in vitro. Neuroscience. 56:1993;23-32.
35. Vizi E.S., Sershan H., Balla H., Mike A., Windish K., Juranyi Z., Lajtha A. Neurochemical evidence of heterogeneity of presynaptic and somatodendritic nAChRs. Ann. N.Y. Acad. Sci. 757:1995;84-99.
36. Westfall T.C., Grant H., Perry H. Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptor. Gen. Pharmacol. 14:1983;321-325.
37. Williams G.V., Goldman-Rakic P. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature. 376:1995;572-575.
38. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:1997;92-98.
39. Zoli M., Lena C., Picciotto M.R., Changeux J.-P. Identification of four classes of brain nicotinic receptors using β2 mutant mice. J. Neurosci. 18:1988;4461-4472.